About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Synergies from Decision Point & operational rigor supporting margins: Postacquisition synergies with Decision Point are driving strong traction in CPG and nearshore markets. The firm plans to scale its nearshore headcount from 20 to 100 over the next year to support localized delivery. Despite higher visa and marketing costs, EBITDA margins remain stable at 2223%, backed by improved utilization and operational efficiency. EBITDA margin guidance for FY26, was revised to 2223% from 23-24% earlier due to focused account initiatives and capability investments in AI CoE and Databricks which should further sustain growth and profitability. Thus, we have baked in EBITDA...
Coforge Ltd (Coforge) is a digital services and solutions provider that leverages its domain experience across sectors such as Banking & Financial Services, Insurance, Government, Travel, Transport and Hospitality....
Q2FY26 performance: Consolidated revenues grew by 8% YoY to Rs.839.5cr in Q2FY26 driven by 7% growth in the standalone revenues and 14% YoY growth in the subsidiaries revenues. Domestic RevPar grew by 9.5% YoY to Rs.8,100/night while ITC Ratnadipa Sri Lanka RevPar grew by 1.6x YoY, witnessing a fast scaleup since its launch in Apr,24. Consolidated EBIDTA margins improved by 200bps YoY to 29.3%; operating EBIDTA grew by 16% YoY to Rs245.8cr. Higher other...
Consistent in delivering superior RoA of 2+% and RoE of 13+% Q2FY26 performance: Kotak Mahindra Bank delivered a steady Q2FY26 performance, marked by advances growth of 16% YoY (4% QoQ), led by strong traction in business banking and mortgages, while deposits rose 15% YoY (3.1% QoQ) with CASA at 42.3%., reflecting strong franchise momentum. NIM stood at 4.54% (11 bps QoQ) as the full impact of repo rate cuts and lower high-yield mix. Credit cost moderated to 79 bps (vs 93 bps in Q1) with improvement in MFI and credit card portfolios, while asset quality remained robust (GNPA/NNPA:...
Strong parentage led distribution remains key catalyst Q2FY26 performance: SBI Life reported a steady Q2FY26 performance, with APE growth of 10% YoY, driven by strong traction in non-par savings (20% of APE) and protection business (33% YoY), while ULIP maintained a balanced 55% share. Bancassurance remained the key growth driver with a 57% APE contribution, supported by healthy productivity in SBI and RRB channels, whereas agency momentum revived in September aided by 64,000 new agent addition and higher non-par share. VNB margin improved to 27.8% (vs 26.8% YoY) despite 80 bps GST...
Q2FY26 Upbeat numbers across parameters - Sales stood at 1654 crore, reflecting a ~35% YoY growth and a growth of ~5.3% QoQ. The CDMO business saw impressive growth of 58% YoY, reaching 471 crore. Generic FDF also grew 58% YoY to 518 crore and the Generic APIs segment grew ~11% YoY to 617 crore. EBITDA stood at 403 crore with a margin of 24.4%, marking a significant improvement of 979 basis points YoY. PAT stood 193.8 crore, driven by a favourable product mix and strong operational performance....
Q2FY26 Performance: Reported revenue came in at 1823 crore, (up 12.4% YoY) with box office revenue of 983 crore (up 17.4% YoY). The footfalls were up ~15% YoY at 44.5 million and (Average Ticket Prices) ATP at 262 was up 1.9% YoY. Ad revenues were up ~15% YoY at 126 crore. F&B revenues were up 12.4% YoY at ...
About the stock: Hindustan Unilever (HUL) is India's largest FMCG company with presence of more than 90 years. The company has portfolio of 50+ brands spanning to various categories such as detergents, personal wash and skin care & colour cosmetics. 80% of revenues come from products having leadership positioning in...
CY24 consolidated revenue mix India 68%, Europe 32%. Forging is over 52% of consolidated sales (84% in Europe and 37% in India). Q3CY25 Results: CIE Automotive India reported healthy performance in Q3CY25. Consolidated revenue for Q3CY25 came in at 2,372 crores, up 11% YoY. EBITDA for the quarter stood at 356 crores with EBITDA margins at 15% (up 80 bps QoQ). CIE India sales were up 9% YoY at 1,523 crore and EBITDA margins at 17.3% (down 20 bps YoY) while European operations witnessed a revenue of 787 crore...
Average ticket size is 25 lakh for housing, 14 lakh for non-housing loans Q2FY26 performance: Canfin Homes reported healthy performance in Q2FY26. Steady disbursement at 2545 crore (6.9%), was offset by pre-payment resulting in AUM growth being broadly steady at 8.4% YoY/ 2.3% QoQ to 39,657 crore. NII grew 19.1% YoY to 405 crore (up 11.5% QoQ), driven by 27 bps YoY/ 38 bps QoQ in margin to ~4%, on the back of reduction in cost of borrowing. Opex remained elevated, keeping CI ratio at 18.55%, however, healthy top-line resulted in 18.9% YoY growth in earnings at 251 crore with RoA at 2.46%. Asset quality remained...
Rallis India Q2FY26: Weak topline performance, Margins remain stable Revenues stood at 861 crore, down 7.2% YoY on account of erratic and prolonged rains which impacted field activities and spray applications. The crop care business (88% of the revenues) reported a decline of 3% YoY at 760 crore, as growth in B2B business (14% YoY) was undone by 10% degrowth in B2C business due to weather disruptions. The seeds business (12% of the revenues) reported a decline of 28% YoY, at 101 crore. EBITDA for the quarter stood at 154 crore, down 7% YoY translating into margins of 18%, up ~220 bps QoQ/ flat YoY. EBITDA for the crop care...
Strong sustenance sales in 360 West, Elysian drive pre-sales: Despite no major launches in Q2FY26, OBEREA reported healthy pre-sales of 1299 crore (down 10% YoY, down 21% QoQ) owing to strong contributions from 360 West ( 446 crore) and Elysian ( 355 crore). Further, its Mulund and Borivali (despite price hikes) projects witnessed healthy sequential improvement post weakness over trailing three quarters. Although on the flip side, Thane project stayed weak over trailing three quarters. Collections too were strong at 1353 crore (up 12% YoY & 36% QoQ)....
About the stock: Mastek Ltd (Mastek) offers data, apps, cloud services to public Geographic strength and strategic focus areas: UK remains Mastek's growth anchor, up 4% QoQ and contributing 65% of revenue, driven by strong demand in Healthcare and Government segments. The company is also restructuring its North America leadership to drive Healthcare growth and emphasis remains on profitability improvement and tighter DSO management.in the Middle East. Continued focus on geo-diversification, AI-led delivery, and mid-market leadership provides visibility for steady, profitable growth through FY2627...
About the stock: IndusInd Bank is a Hinduja group promoted newer age private sector bank and is the fifth largest private bank in India. The bank has full product suite with strong moat in vehicle and micro finance business. The bank has a strong presence with pan India branch network of 3,116...
Component strategy execution to be key factor ahead manufacturing services (EMS) company of India offering comprehensive EMS solutions with specialized focus across product verticals including mobile, television, washing machine, refrigerators, laptop, lighting, telecom, wearables and hearables, AC printed circuit boards (PCBs), etc. Q2FY26 performance: Dixon reported revenue of 14,855 crore (up by (29% YoY/15% QoQ). Mobile and EMS division continued its healthy growth with revenue of 13,361 crore (up by 41% YoY/15% QoQ). Company is in-line to achieve 40-42...
Prudent management, strong execution track record, healthy order book, strong balance sheet and robust return ratios are the key strengths of PSP. Q2FY26 Performance: The standalone revenue of 694 crore, was up 20% YoY, attributable to improved project execution which driven by better workflow, and improved labour activity post monsoon season. EBITDA at 48.1 crore, up 23.8%...
Q2FY26 performance: Consolidated revenue increased by 25.4% YoY (-7.8% QoQ) to Rs 19606.9 crore, led by 21.6% YoY volume growth to 33.85 mtpa and realisation improvement by 3.1% YoY (+s0.3% QoQ). EBITDA/ton improved by 26.1% YoY (-23.7% QoQ) to Rs 914/ton. Subsequently, EBITDA was up 53.3% YoY (-29.8%...
Q2FY26 performance: IDFC First Bank reported a mixed Q2FY26 performance as healthy loan and deposit growth was offset by margin pressure and lower treasury gains. NII rose 6.8% YoY to 5,113 crore, while NIM contracted 12 bps QoQ to 5.6%. Provisions moderated to 1,452 crore, aiding PAT of 352 crore (up 76% YoY, down 24% QoQ). Asset quality improved with GNPA/NNPA at 1.86%/0.52%. Funded assets expanded 19.7% YoY to 2.67 lakh crore led by mortgage, vehicle and...